Causaly Introduces Scientific Workflows for Automated Life Sciences Research
Causaly announced in a press release the launch of Scientific Workflows, a new solution in its AI platform that converts expert scientific processes into repeatable workflows executed by multiple AI agents. The system produces structured, evidence-backed outputs such as target assessments, indication exploration reports, and safety dossiers to support consistent research across R&D programs.
Scientific Workflows allows life sciences organizations to codify their best scientific methods and standard operating procedures into governed processes that can be executed autonomously. Each workflow includes checkpoints for human oversight and creates traceable, auditable outputs to ensure scientific rigor and reproducibility.
According to Causaly, the platform’s multi-agent orchestration enables coordination between AI agents, allowing them to share context and manage handoffs across complex R&D tasks. Early deployments have shown that the system can reduce manual research time by up to a month per indication for large pharmaceutical companies.
The solution is available in ready-to-run formats for common R&D processes or can be tailored to reflect an organization’s unique scientific practices and data. Causaly also offers integration with private data sources through its Causaly Private Data feature, enabling secure use of internal and external evidence in research workflows.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Nov 13 Bracco and Avicenna.AI win FDA clearance for AI that flags brain aneurysms on CT scans Nov 13 Zus Health raises $33 million to build the data layer for healthcare AI Nov 13 Google DeepMind releases AlphaGenome 2 to predict DNA variant effects in specific cell types Nov 13 Taiwan hospital accelerator T+ MedIC names AI ECG and CT screening tools as first winners Nov 13 Sheinbaum meets OpenAI president Greg Brockman on AI in Mexican healthcareLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Inovia Bio Launches Falcon for Drug Development Workflows
Asuri.ai Launches Multi Agent Platform for Business Workflows
Phylo Brings Biomni Lab AI Agents to Bayer
AIPOCH Releases Open-Science Research Workbench
Warp Sciences Raises $215 Million to Automate Drug Discovery Labs
Daily AI Brief: the AI news that matters, in your inbox.